# Daily Hospital Course Framework v1

Date created: 2026-06-01

Status: CANDIDATE REVIEW.

Purpose: define the canonical HD1-HD6 evolution model for Korvin Merrow before World Spec construction, file inventory architecture, synthetic file construction, task implementation, prompt construction, expected outputs, golden responses, or grader guidance.

This package answers: what changes on each hospital day?

This package does not create labs, lab trends, vitals, medication doses, medication schedules, medication orders, consultant notes, discharge summaries, operative reports, procedure notes, file inventory, tasks, task prompts, expected outputs, golden responses, grader guidance, synthetic files, World Spec prose, templates, or reference files.

## Source Constraints

Use only:

- Approved Brainstorm.
- Locked Identity Package v1.
- Ratified Governance Package v1.
- Locked Key Milestones Calendar Skeleton v1.
- Locked Baseline Anchor Package v1.
- Locked Clinical Story Timeline Package v1.
- Locked Task Architecture Package v1.
- Locked Medication Expansion Package v1.
- Locked Comorbidity Expansion Package v1.
- Locked Provider Roster Package v1.
- Locked Surgical History Package v1.
- Current Clinical Logic.

## Design Doctrine

This framework is the bridge between architecture and actual spec construction.

It is intentionally more specific than the Clinical Story Timeline Package, but it remains less specific than:

- final World Spec prose;
- Section 3 file inventory;
- synthetic chart files;
- task prompts;
- expected outputs;
- golden responses;
- grader guidance.

The correct level of detail is architecture-level daily evolution:

- what is true;
- what changed;
- what improved;
- what remains concerning;
- which frictions and traps are active;
- which provider groups become relevant;
- how disposition readiness evolves.

It must preserve:

- mixed physiology;
- no hidden single answer;
- no reveal-drift;
- improving but not safely solved;
- medically improving but operationally dangerous;
- both sides of each friction as clinically defensible.

## Locked Temporal Frame

- HD1 / admission: 05/18/2026.
- HD2: 05/19/2026.
- HD3: 05/20/2026.
- HD4: 05/21/2026.
- HD5: 05/22/2026.
- HD6 / world close day: 05/23/2026.
- World close: 05/23/2026 18:00.
- Discharge anchor: 05/24/2026.
- +7 anchor from discharge: 05/31/2026.
- +30 anchor from discharge: 06/23/2026.

This framework covers HD1-HD6 only. Discharge, +7, and +30 remain task anchors or post-world reference anchors, not hospital-course days.

## Active Frictions

Use ratified Governance Package labels:

1. Cardiology vs Nephrology: medication restart timing.
2. Family vs Primary Team: discharge readiness.
3. Endocrinology vs Primary Team: steroid interpretation and risk.

## Active Traps

Use approved trap architecture:

1. Steroid timeline/source-of-truth trap.
2. HF/AKI medication reconciliation and time-sensitive consultant trap.
3. Buried functional/cognitive status trap.
4. Sepsis anchoring after partial improvement trap.
5. Discharge plan source-hierarchy trap.

## 1. HD1-HD6 Daily Evolution Framework

| Hospital day | Primary clinical state | What changed since prior day | What improved | What remains concerning | Active friction(s) | Active trap(s) | Provider groups relevant | Disposition readiness status |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| HD1 / 05/18/2026 | Acute presentation and stabilization. Korvin enters the hospital as an undifferentiated medically complex patient with suspected urinary-source infection, poor intake, altered baseline cognition, weakness, near-fall context, volume/renal vulnerability, and high medication complexity. Sepsis-oriented management is reasonable. | The case moves from home decline into acute hospital evaluation. The initial clinical frame becomes infection plus stabilization rather than outpatient chronic disease management. | Initial stabilization begins. The patient is now observed in a controlled setting, and family baseline information becomes available to the care team. | Infection may be only one contributor. Steroid history is not yet reliable. Baseline medication truth is uncertain. Functional decline is present but may be underweighted during acute stabilization. | Family vs Primary Team is latent because family provides baseline deviation. Cardiology vs Nephrology is seeded by acute illness and medication safety. Endocrinology vs Primary Team is not yet fully active. | Trap #1 is present but not fully recognized. Trap #2 begins through acute illness medication safety. Trap #4 is established as a reasonable initial anchor. Trap #3 is seeded by pre-admission function/cognition. | ED/primary hospital team, family, nursing, pharmacy/medication reconciliation. Consultants are not yet dominant. | Not discharge ready. The priority is stabilization and initial diagnostic framing. |
| HD2 / 05/19/2026 | Early inpatient reassessment after initial stabilization. Some clinical features begin to improve, but the case remains mixed physiology rather than a completed infection story. | The patient transitions from emergency stabilization to inpatient management. Consultant involvement begins or becomes clinically justified. | Initial treatment response makes the patient appear less acutely unstable. Renal/hemodynamic and infection concerns begin to move from initial crisis into trend interpretation. | Improvement may encourage premature closure. Medication holds/restarts are not yet settled. Steroid timeline remains inconsistent. Functional reserve is still incompletely assessed. | Cardiology vs Nephrology begins to emerge around medication safety versus long-term protection. Endocrinology vs Primary Team begins to emerge if steroid exposure is recognized as uncertain. Family vs Primary Team remains mostly latent. | Trap #2 is reinforced by time-sensitive medication decisions. Trap #1 is reinforced by inconsistent steroid sources. Trap #4 begins after partial improvement. | Hospitalist service, nephrology, cardiology, endocrinology if consulted, pharmacy, nursing, family. | Not discharge ready. The patient is improving but remains clinically unsettled and functionally under-characterized. |
| HD3 / 05/20/2026 | Functional and cognitive recovery becomes a central concern. The patient is clinically less acute but not back to baseline. | The center of attention begins shifting from acute stabilization alone toward whether the patient can safely function after hospitalization. | Some infection/acute-illness features continue to improve. The team has more inpatient observation. | Weakness, cognitive fluctuation, mobility limitations, medication-management vulnerability, and deviation from baseline remain concerning. Functional evidence may be buried outside physician summary notes. | Family vs Primary Team begins to activate as family baseline knowledge becomes clinically important. Cardiology vs Nephrology may continue in the background. Endocrinology vs Primary Team remains possible if persistent weakness or hemodynamic concerns are interpreted differently. | Trap #3 becomes active through nursing/PT/OT/family evidence. Trap #4 remains active if improvement is over-interpreted. Trap #2 persists. Trap #1 remains unresolved. | Hospitalist service, nursing, PT/OT, family, pharmacy, cardiology/nephrology/endocrinology as needed. | Not discharge ready. Functional readiness is not yet established even if medical trajectory is improving. |
| HD4 / 05/21/2026 | Consultant disagreement and source-of-truth problems become explicit. The patient is no longer only an acute stabilization problem; the key work is reconciling competing reasonable interpretations. | Specialist recommendations become more meaningful and more time-sensitive. Steroid-history inconsistency is recognized as clinically relevant but not perfectly resolved. | Some acute illness features continue to move in the right direction. More information exists across services and chart sources. | The correct medication restart strategy is unsettled. Steroid/adrenal risk remains interpretive, not a single-answer reveal. Consultant recommendations may reflect different timestamps and assumptions. | Cardiology vs Nephrology is active. Endocrinology vs Primary Team is active. Family vs Primary Team is emerging but not yet the main conflict. | Trap #1 is strongly active. Trap #2 is active. Trap #4 persists because sepsis improvement can obscure other contributors. Trap #3 continues as functional/cognitive evidence accumulates. | Hospitalist service, cardiology, nephrology, endocrinology, pharmacy, nursing, PT/OT, family. Outpatient rheumatology/PCP may matter as provenance, not as inpatient actors. | Not discharge ready. The patient requires synthesis of consultant input, medication risk, steroid interpretation, and functional trajectory. |
| HD5 / 05/22/2026 | Disposition questions become dominant. The patient appears medically improved enough that discharge planning is plausible, but safety remains uncertain. | The case shifts from "what is the diagnosis?" toward "is the patient safe to leave, and under what plan?" | The overall acute trajectory is improved compared with admission. More consultant and functional information is available. | Functional reserve, cognition, medication plan coherence, family confidence, follow-up reliability, and steroid interpretation remain unresolved enough to matter. A visible discharge-facing artifact may look more complete than it is. | Family vs Primary Team becomes active. Cardiology vs Nephrology remains relevant through final medication plan. Endocrinology vs Primary Team remains relevant through steroid plan and risk interpretation. | Trap #5 is established. Trap #3 remains active and must be distinguished from Trap #5. Trap #2 and Trap #1 remain actionable. Trap #4 remains a risk if partial infection improvement is treated as full explanation. | Hospitalist service, family, nursing, PT/OT, case management, social work, pharmacy, consultants. | Possibly approaching discharge readiness, but not safely solved. Discharge is clinically plausible but requires careful synthesis. |
| HD6 / 05/23/2026 | World close day. Korvin is medically improved compared with presentation, but discharge remains operationally dangerous if functional, medication, steroid, consultant, and family concerns are not integrated. | The world reaches its closed inpatient snapshot at 18:00 during discharge planning. Future tasks must occur after this state. | Acute clinical stabilization is meaningfully improved. The team has more data, more consultant input, and more discharge-planning information than earlier in the stay. | Functional reserve remains uncertain. Medication restart/hold logic must be coherent. Steroid source-of-truth remains imperfect. Family concern remains defensible. A reassuring discharge plan may be incomplete if trusted alone. | All three frictions are active: Cardiology vs Nephrology, Family vs Primary Team, and Endocrinology vs Primary Team. | All major traps remain available. Trap #3 and Trap #5 must stay distinct. No trap is resolved by one document or one diagnosis. | Hospitalist service, cardiology, nephrology, endocrinology, nursing, PT/OT, case management, social work, pharmacy, family, PCP/rheumatology as provenance sources. | Discharge may be defensible, but safe discharge is not automatic. The correct decision requires synthesis across the whole world. |

## 2. Improvement Trajectory Framework

### Genuinely Improves

- Acute stabilization improves compared with presentation.
- Suspected infection/acute illness burden improves enough that the initial sepsis frame is no longer the only active question.
- Oral intake and overall alertness improve compared with the ED presentation.
- Renal/hemodynamic trajectory improves enough that medication strategy must be reassessed rather than simply copied from early holds.
- The team gains more information from consultants, bedside observation, functional assessment, family input, and medication-source review.

### Partially Improves

- AKI on CKD improves but does not simply reset the patient to baseline risk.
- Cognition improves compared with presentation but remains vulnerable enough that family and nursing observations matter.
- Weakness improves enough to make discharge discussable, but not enough to erase functional risk.
- Medication management becomes more organized in the hospital but remains difficult to translate safely back home.
- Steroid risk becomes better recognized but remains an interpretive question, not a proven single cause.

### Appears Improved But Remains Dangerous

- "Clinically improved" can be true while discharge remains unsafe or poorly coordinated.
- A visible discharge plan may appear complete while omitting buried functional/cognitive evidence or unresolved consultant tensions.
- Improved infection framing can obscure persistent noninfectious contributors.
- A medication plan can look reasonable in one specialty note while becoming unsafe or incomplete when renal recovery, cardiac protection, hypotension risk, and discharge context are integrated.

### Unresolved At World Close

- Whether Korvin is functionally safe enough for the planned disposition.
- Whether the medication restart/hold/taper plan is coherent across services.
- Whether steroid exposure and taper history are interpreted safely without making adrenal insufficiency the hidden answer.
- Whether family concern has been incorporated rather than merely acknowledged.
- Whether transition planning accounts for cognition, mobility, medication-management ability, follow-up, and caregiver capacity.

## 3. Friction Activation Timeline

### Cardiology vs Nephrology

Activation:

- Seeded on HD1 by AKI/CKD, borderline hemodynamic concern, HFrEF/CAD, and medication complexity.
- Becomes active on HD2 as early medication safety and cardioprotective therapy questions emerge.

Peak:

- Peaks on HD4-HD5 when evolving renal/hemodynamic status makes early holds and later restart strategy time-sensitive.

Partial resolution:

- Begins to resolve only if the primary team synthesizes timing, patient status, renal recovery, cardiac risk, and discharge context.
- It is not resolved by automatically choosing the latest note or the highest-authority service.

World-close status:

- Still relevant at HD6 because discharge medication planning must reconcile both perspectives.

### Family vs Primary Team

Activation:

- Seeded before admission through family recognition of meaningful deviation from baseline.
- Becomes clinically active on HD3 when functional/cognitive concerns persist despite medical improvement.

Peak:

- Peaks on HD5-HD6 when discharge planning becomes plausible but family continues to see unresolved functional and real-world safety risk.

Partial resolution:

- Begins only if the discharge plan integrates functional status, cognitive trajectory, medication-management burden, caregiver capacity, and follow-up.

World-close status:

- Still active. Both family concern and primary-team discharge reasoning remain defensible.

### Endocrinology vs Primary Team

Activation:

- Seeded by PMR history, chronic prednisone exposure, and inconsistent taper/source information.
- Becomes active around HD2-HD4 as persistent weakness, borderline symptoms, and steroid-history uncertainty become harder to ignore.

Peak:

- Peaks when the team must decide whether steroid risk should alter evaluation, taper planning, and discharge safety.

Partial resolution:

- Begins only if steroid history is reconstructed using the prednisone source-of-truth hierarchy and interpreted in context.

World-close status:

- Relevant but not dominant. Steroid physiology is important, but the world must not become a hidden adrenal-insufficiency case.

## 4. Trap Activation Timeline

### Trap #1: Prednisone Source-of-Truth

Establishment phase:

- Pre-admission through HD1. PMR, chronic prednisone exposure, taper history, family uncertainty, patient recollection, medication lists, and outpatient source ambiguity create the trap.

Reinforcement phase:

- HD2-HD4. Inpatient teams recognize that steroid status is clinically relevant, but sources do not line up cleanly.

World-close status:

- Active. The clinician must reconstruct enough of the exposure timeline to guide safe reasoning without treating adrenal insufficiency as the single hidden answer.

### Trap #2: HF/AKI Medication Reconciliation

Establishment phase:

- HD1-HD2. Acute illness and AKI/CKD justify medication safety concerns and early holds/adjustments.

Reinforcement phase:

- HD3-HD5. The patient's condition changes, and earlier recommendations may no longer apply exactly as written.

World-close status:

- Active. The agent must avoid both premature full restart and unsafe discharge without reviewing long-term protective therapy.

### Trap #3: Buried Functional/Cognitive Status

Establishment phase:

- Pre-admission through HD3. Family baseline deviation, nursing observations, and PT/OT concerns create important evidence that may sit outside the most obvious physician summary.

Reinforcement phase:

- HD3-HD6. Functional and cognitive concerns persist even as medical stabilization improves.

World-close status:

- Active. The issue is whether the agent finds and integrates the buried evidence.

### Trap #4: Sepsis Anchoring After Partial Improvement

Establishment phase:

- HD1. Sepsis-oriented framing is clinically reasonable and appropriate.

Reinforcement phase:

- HD2-HD5. Improvement in infection/acute illness can tempt premature closure.

World-close status:

- Active. The correct reasoning is that sepsis may have been real or reasonable initially, but it does not explain the whole hospitalization or discharge risk.

### Trap #5: Discharge Source-Hierarchy

Establishment phase:

- HD5. Discharge planning becomes a visible artifact or workflow target.

Reinforcement phase:

- HD5-HD6. A discharge-facing plan can look sufficient if trusted alone, especially if it underweights buried functional/cognitive evidence, consultant timing, medication complexity, or family concerns.

World-close status:

- Active. The issue is over-trusting a visible but incomplete source.

### Trap #3 vs Trap #5 Preservation

- Trap #3 asks: did the clinician find the important functional/cognitive evidence?
- Trap #5 asks: after seeing a reassuring discharge-facing artifact, did the clinician recognize it was incomplete and reconcile it against the rest of the world?

These must remain distinct during later file construction.

## 5. Provider Involvement Timeline

| Provider group / stakeholder | When each becomes relevant | Why each matters |
| --- | --- | --- |
| Hospitalist / primary inpatient team | HD1-HD6 | Owns inpatient synthesis, stabilization, consultant integration, discharge-readiness interpretation, and final risk balancing. |
| Cardiology | HD2-HD6 | Represents HFrEF/CAD protection and GDMT restart logic; central to Cardiology vs Nephrology and medication reconciliation. |
| Nephrology | HD2-HD6 | Represents AKI-on-CKD recovery, hypotension/volume safety, and renal-sensitive medication logic. |
| Endocrinology | HD2-HD6, strongest HD4-HD6 | Interprets steroid/adrenal risk and taper safety without becoming the source of a hidden single diagnosis. |
| PCP influence | Pre-admission provenance and discharge/follow-up planning | Provides longitudinal chronic disease, medication, baseline function, and transition context; not an inpatient decision-maker. |
| Rheumatology influence | Pre-admission provenance, especially HD4-HD6 steroid reconstruction | Highest-authority prednisone-history source through outpatient PMR/taper documentation; not an inpatient friction participant unless later explicitly created. |
| Nursing | HD1-HD6 | Provides bedside cognition, intake, mobility, family communication, and practical safety observations that may become buried evidence. |
| PT/OT | HD3-HD6 | Provides functional and ADL evidence central to discharge safety and the Family vs Primary Team friction. |
| Case Management | HD5-HD6 | Coordinates discharge services, home support, equipment/placement considerations, and transition logistics without making discharge automatically safe. |
| Social Work | HD5-HD6 | Assesses caregiver capacity, psychosocial barriers, and support needs relevant to family/team friction. |
| Pharmacy / medication reconciliation | HD1-HD6, strongest HD4-HD6 | Supports verified medication history, steroid and HF medication source reconciliation, and discharge medication safety. |
| Family / Mara Merrow | Pre-admission through HD6 | Carries baseline function/cognition knowledge, home safety concerns, and real-world medication-management concerns. |

## 6. Disposition-Safety Framework

### Why Discharge Becomes Reasonable

- The patient is medically improved compared with admission.
- Acute stabilization has occurred.
- Some infection/acute-illness features have improved.
- Renal/hemodynamic concerns appear improved enough for reassessment rather than continued automatic holding of all chronic therapy.
- Mental status and intake are improved compared with presentation.
- Consultant recommendations and discharge-planning resources exist.
- Follow-up can be arranged.

### Why Discharge Remains Risky

- Functional reserve remains below baseline or uncertain.
- Cognitive recovery may be incomplete or fluctuating.
- Medication plan is complex and changed from baseline.
- Steroid history and taper interpretation remain imperfect.
- Consultant recommendations are time-sensitive and may appear conflicting if not contextualized.
- Family still observes meaningful deviation from baseline.
- A discharge-facing plan may appear reassuring while failing to integrate all relevant evidence.

### Why Family Concern Remains Defensible

- Family knows baseline function, cognition, and home medication-management capacity.
- Family observed the pre-admission decline and near-fall.
- Family can reasonably worry that improved numbers or improved appearance do not equal safe home function.
- Family concern is not merely emotional resistance; it is clinically relevant longitudinal evidence.

### Why Primary Team Position Remains Defensible

- The patient has improved compared with admission.
- Acute issues appear controlled enough to make discharge planning plausible.
- Continued hospitalization has its own risks and may not be necessary if supports and follow-up are adequate.
- The primary team must balance medical stability, consultant recommendations, resource realities, and transition planning.

### Required Balance

Neither side should be obviously correct.

The world should force the agent to ask:

- Is Korvin medically stable on paper?
- Is he actually safe in the real-world discharge environment?
- Has the plan integrated functional evidence, medication changes, consultant timing, steroid uncertainty, family concerns, and follow-up?

## 7. Future Construction Compatibility Review

### World Spec Construction

Compatibility:

- Provides HD1-HD6 architecture for later Clinical Scenario and Key Milestones construction.
- Does not create final World Spec prose.

### File Inventory Architecture

Compatibility:

- Identifies what future files must support without naming files, creating file rows, or specifying document counts.
- Preserves later decisions about where evidence appears.

### Synthetic File Construction

Compatibility:

- Establishes daily evolution all future synthetic documents must inherit.
- Does not create note content, file content, or source documents.

### Task Construction

Compatibility:

- Supports locked task architecture by preserving medication reconciliation, discharge summary, discharge planning, consultant synthesis, follow-up, and safety review reasoning.
- Does not create prompts, task inputs, expected outputs, or task-specific facts.

### Prompt Construction

Compatibility:

- Future prompts can anchor after the world close and draw from this daily evolution.
- No prompt is created here.

### Golden Construction

Compatibility:

- Future goldens can use this framework to evaluate whether an answer integrates the right evolution.
- No golden response is created here.

### Grader Guidance Construction

Compatibility:

- Future grader guidance can use this framework to define expected reasoning domains.
- No grader guidance is created here.

## Daily Hospital Course Framework Consistency Review

### VERIFIED

Finding: consistent with locked Clinical Story Timeline Package v1.

Evidence: the framework preserves HD1 admission/stabilization, HD2 partial improvement and consultant involvement, HD3 PT/OT functional concerns, HD4 consultant tensions and steroid-history inconsistency, HD5 disposition focus, and HD6 world close during discharge planning.

Impact: no timeline redesign occurs.

Action required: physician review before lock.

### VERIFIED

Finding: consistent with locked Baseline Anchor Package v1.

Evidence: baseline function, cognition, medication-management ability, home support, dry weight/volume context, renal baseline, hemoglobin baseline, and A1c baseline remain comparator concepts only.

Impact: baseline anchors remain useful without becoming admission labs or hospital-course trends.

Action required: do not convert baseline anchors into hospital-day values here.

### VERIFIED

Finding: consistent with locked Medication Expansion Package v1.

Evidence: the framework supports medication complexity and restart/hold reasoning without naming daily medication orders, doses, schedules, or reconciliation outputs.

Impact: medication architecture remains intact.

Action required: preserve inpatient glycemic-management and medication-reconciliation construction for later authorized phases.

### VERIFIED

Finding: consistent with locked Comorbidity Expansion Package v1.

Evidence: the framework uses HFrEF/CAD/CKD/diabetes/PMR/OSA/neuropathy/anemia/osteoporosis/obesity/GERD/constipation as background architecture without creating a new dominant disease arc.

Impact: comorbidity burden supports realism without taking over the story.

Action required: none before physician review.

### VERIFIED

Finding: consistent with locked Provider Roster Package v1.

Evidence: provider groups map to hospitalist, cardiology, nephrology, endocrinology, PCP, rheumatology, nursing, PT/OT, case management, social work, pharmacy, and family without creating notes or encounters.

Impact: provider architecture remains provenance/role logic only.

Action required: do not create provider-authored documents here.

### VERIFIED

Finding: consistent with locked Surgical History Package v1.

Evidence: remote PCI supports CAD/cardiology context and remote sleep study supports OSA baseline context, while neither becomes an acute hospital-course event.

Impact: surgical/procedural history remains quiet background architecture.

Action required: keep PCI remote and defer procedural provenance to file inventory.

### VERIFIED

Finding: friction continuity is preserved.

Evidence: Cardiology vs Nephrology activates through medication restart timing; Family vs Primary Team activates through discharge readiness; Endocrinology vs Primary Team activates through steroid interpretation and risk.

Impact: no friction collapses into a single obvious correct side.

Action required: later construction must preserve both sides as defensible.

### VERIFIED

Finding: trap continuity is preserved.

Evidence: the framework activates steroid source-of-truth, HF/AKI medication reconciliation, buried functional/cognitive evidence, sepsis anchoring after partial improvement, and discharge source hierarchy across the admission.

Impact: traps remain multi-document synthesis problems rather than single-document findings.

Action required: later file construction must preserve Trap #3 vs Trap #5 distinction.

### VERIFIED

Finding: mixed physiology is preserved.

Evidence: infection, volume/renal vulnerability, HF/CAD medication reasoning, steroid uncertainty, neuropathy, deconditioning, cognition, and functional reserve all remain contributors.

Impact: the world does not become a sepsis-only case or a hidden adrenal-insufficiency case.

Action required: maintain this balance during future construction.

### VERIFIED

Finding: discharge-safety design is preserved.

Evidence: HD5-HD6 make discharge clinically plausible but not automatically safe, preserving the medically improving / operationally dangerous theme.

Impact: primary failure target remains disposition safety and discharge-readiness reasoning.

Action required: none before physician review.

### VERIFIED

Finding: source-of-truth preservation is maintained.

Evidence: prednisone, medication reconciliation, consultant timing, family baseline, nursing/PT/OT observations, and discharge-facing artifacts are all treated as source problems to synthesize later.

Impact: later World Spec and file construction can build traceability without this package becoming file inventory.

Action required: defer file provenance decisions.

### VERIFIED

Finding: temporal continuity is preserved.

Evidence: HD1-HD6 align with locked dates and world close at 05/23/2026 18:00. Post-world anchors are referenced only as future task or transition anchors.

Impact: supports later AutoQC temporal gates.

Action required: do not add post-world events here.

### PLAUSIBLE

Finding: HD4 is the best peak point for consultant conflict.

Evidence: HD4 sits after initial stabilization and before discharge planning dominates, making it a realistic day for consultant tension and source-of-truth conflict to become explicit.

Impact: supports realistic hospital flow.

Action required: physician reviewer may refine timing before lock if desired.

### PLAUSIBLE

Finding: HD5 is the best establishment point for the discharge source-hierarchy trap.

Evidence: HD5 is when discharge planning becomes dominant but before HD6 world close, allowing visible discharge-facing artifacts to become tempting but incomplete.

Impact: supports Trap #5 without merging it into Trap #3.

Action required: preserve distinction during later file construction.

### NO ISSUE

Finding: this package creates no prohibited downstream artifacts.

Evidence: it contains no labs, lab trends, vitals, medication doses, medication schedules, orders, notes, discharge summary, operative report, procedure note, file inventory, tasks, prompts, expected outputs, goldens, grader guidance, templates, reference files, synthetic documents, or World Spec prose.

Impact: phase boundary remains intact.

Action required: stop before downstream construction.

### DISPUTED

Finding: none.

Evidence: no framework element contradicts the approved Brainstorm, locked Identity Package, ratified Governance Package, locked Calendar Skeleton, locked Baseline Anchor Package, locked Clinical Story Timeline Package, locked Task Architecture Package, locked Medication Expansion Package, locked Comorbidity Expansion Package, locked Provider Roster Package, locked Surgical History Package, or current Clinical Logic.

Impact: no redesign required before physician review.

Action required: none.

## Final Status

Daily Hospital Course Framework v1

Status: CANDIDATE REVIEW
